Daniel Onah

Binxia Xu, Antonis Bikakis, Daniel Onah et al.

Given that AI systems are set to play a pivotal role in future decision-making processes, their trustworthiness and reliability are of critical concern. Due to their scale and complexity, modern AI systems resist direct interpretation, and alternative ways are needed to establish trust in those systems, and determine how well they align with human values. We argue that good measures of the information processing similarities between AI and humans, may be able to achieve these same ends. While Representational alignment (RA) approaches measure similarity between the internal states of two systems, the associated data can be expensive and difficult to collect for human systems. In contrast, Behavioural alignment (BA) comparisons are cheaper and easier, but questions remain as to their sensitivity and reliability. We propose two new behavioural alignment metrics misclassification agreement which measures the similarity between the errors of two systems on the same instances, and class-level error similarity which measures the similarity between the error distributions of two systems. We show that our metrics correlate well with RA metrics, and provide complementary information to another BA metric, within a range of domains, and set the scene for a new approach to value alignment.

Maria De La Luz Lomboy Toledo, Daniel Onah

Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to impaired insulin production or function. Two main forms are recognized: type 1 diabetes (T1D), which involves autoimmune destruction of insulin-producing \b{eta}-cells, and type 2 diabetes (T2D), which arises from insulin resistance and progressive \b{eta}-cell dysfunction. Understanding the molecular mechanisms underlying these diseases is essential for the development of improved therapeutic strategies, particularly those targeting \b{eta}-cell dysfunction. To investigate these mechanisms in a controlled and biologically interpretable setting, mouse models have played a central role in diabetes research. Owing to their genetic and physiological similarity to humans, together with the ability to precisely manipulate their genome, mice enable detailed investigation of disease progression and gene function. In particular, mouse models have provided critical insights into \b{eta}-cell development, cellular heterogeneity, and functional failure under diabetic conditions. Building on these experimental advances, this study applies machine learning methods to single-cell transcriptomic data from mouse pancreatic islets. Specifically, we evaluate two supervised approaches identified in the literature; Extra Trees Classifier (ETC) and Partial Least Squares Discriminant Analysis (PLS-DA), to assess their ability to identify T2D-associated gene expression signatures at single-cell resolution. Model performance is evaluated using standard classification metrics, with an emphasis on interpretability and biological relevance

Daniel Onah, Ravish Desai

In recent years, deep learning has shown great promise in the automated detection and classification of brain tumors from MRI images. However, achieving high accuracy and computational efficiency remains a challenge. In this research, we propose Deep Brain Net, a novel deep learning system designed to optimize performance in the detection of brain tumors. The model integrates the strengths of two advanced neural network architectures which are EfficientNetB0 and ResNet50, combined with transfer learning to improve generalization and reduce training time. The EfficientNetB0 architecture enhances model efficiency by utilizing mobile inverted bottleneck blocks, which incorporate depth wise separable convolutions. This design significantly reduces the number of parameters and computational cost while preserving the ability of models to learn complex feature representations. The ResNet50 architecture, pre trained on large scale datasets like ImageNet, is fine tuned for brain tumor classification. Its use of residual connections allows for training deeper networks by mitigating the vanishing gradient problem and avoiding performance degradation. The integration of these components ensures that the proposed system is both computationally efficient and highly accurate. Extensive experiments performed on publicly available MRI datasets demonstrate that Deep Brain Net consistently outperforms existing state of the art methods in terms of classification accuracy, precision, recall, and computational efficiency. The result is an accuracy of 88 percent, a weighted F1 score of 88.75 percent, and a macro AUC ROC score of 98.17 percent which demonstrates the robustness and clinical potential of Deep Brain Net in assisting radiologists with brain tumor diagnosis.